Denosumab superior to zoledronic acid for breast cancer patients with bone metastases (EurekAlert, 14 August 2012)

15 Aug 2012


A phase III study by an international team of researchers published in Clinical Cancer Research examines bone-related events and health-related quality of life in patients with breast cancer and bone metastases given either denosumab or zoledronic acid.

Full article


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story